View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Minocycline, a derivative of tetracycline, appears to reduce disability from acute ischemic stroke, even given up to 24 hours after the onset of signs and symptoms. Most other treatments must be given 3 to 6 hours after symptom onset to offer any benefit.
In a study, 74 patients who received 200 mg of minocycline orally for 5 days were compared with 77 patients who received a placebo. Therapy was initiated between 6 and 24 hours after stroke onset. Researchers used standard stroke scoring systems to assess patients' functional disability for 90 days.
Patients treated with minocycline had significantly reduced disability compared with patients who received a placebo. Minocycline's benefits were evident within 1 week of the stroke. No differences in deaths, myocardial infarction, recurrent stroke, or hemorrhagic transformation were found between the two groups. The results are consistent with earlier animal research showing that minocycline has a neuroprotective effect.
The researchers call for more study to determine the optimal dose and to examine the effectiveness of intravenous minocycline.
Source: Lampl Y, et al., Minocycline treatment in acute stroke: An open-label, evaluator-blinded study, Neurology, October 2, 2007.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top